The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns

Details

Language :

English

ISSN :

01519638

Volume :

151

Issue :

1

Database :

Supplemental Index

Journal :

Annales de Dermatologie et de Vénéréologie

Publication Type :

Periodical

Accession number :

ejs65032473

Full Text :

https://doi.org/10.1016/j.annder.2023.103243